Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Elmer

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Community Mental Health Journal|January 1, 1978
Child abuse training: a community-based interdisciplinary programE Elmer, H G Bennett, N Harway, et al.
Cancer|April 25, 2003
Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomitingSant P Chawla, Steven M Grunberg, Richard J Gralla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2003
The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study GroupPaul J Hesketh, Steven M Grunberg, Richard J Gralla, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Community Mental Health Journal|January 1, 1978
Child abuse training: a community-based interdisciplinary programE Elmer, H G Bennett, N Harway, et al.
Cancer|April 25, 2003
Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomitingSant P Chawla, Steven M Grunberg, Richard J Gralla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2003
The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study GroupPaul J Hesketh, Steven M Grunberg, Richard J Gralla, et al.
Pageof 2